WGS GeneDx Holdings Corp.
$61.26▲ +9.10%
Healthcare
Other
Volume 1.00M
Avg Volume (10D) 858.3K
Key Metrics & Fundamentals
Market Cap
$1.83B
P/E Ratio
–
Div Yield
0.00%
52W Range
32.21 - 170.87
% vs 50 MA
-23.43%
% vs 200 MA
-16.01%
RSI-14
38.7
MACD Histogram
-0.4400
Beta (1Y vs SPY)
1.56
Free Cash Flow
-$39.10M
Gross Rev
$114.44M
Gross Profit
$78.24M
EBITDA
-$8.15M
COGS
$36.20M
Operating Exp
$93.48M
Operating Income
-$15.24M
EBIT
-$15.24M
Pretax Income
-$18.26M
Net Income
-$17.74M
EPS (Diluted)
-0.60
Price & Volume History
Loading chart…
Recent News
GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
Business Wire · Oct 23, 2026 4:05 PM ET
How Long Can GeneDx Keep Burning Cash?
Trefis · Oct 21, 2026 12:23 PM ET
Sector Update: Healthcare Stocks Gain Late Afternoon
MT Newswires · Oct 20, 2026 3:53 PM ET
Sector Update: Healthcare Stocks Gain Tuesday Afternoon
MT Newswires · Oct 20, 2026 1:38 PM ET
GeneDx to Add Long-Read Whole Genome Sequencing to Testing Portfolio
MT Newswires · Oct 20, 2026 9:28 AM ET
GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis
Business Wire · Oct 20, 2026 8:30 AM ET
GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026
Business Wire · Oct 19, 2026 4:05 PM ET
GeneDx Holdings And 2 Other Top Healthcare Stocks
Simply Wall St. · Oct 17, 2026 11:11 AM ET
Top 3 Healthcare Stocks To Watch In October 2026
Simply Wall St. · Oct 10, 2026 10:17 AM ET
Teladoc Strengthens Solo Platform With New AI-Powered Care Tools
Zacks · Oct 8, 2026 10:47 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See WGS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.